Search database
Filter
19
Text search: M. Vicari
Featured
Language
Document type
No document type
7
Studies & Reports
4
Guidelines
3
Manuals
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Guinea
1
Somalia
1
Western and Central Europe
1
Global
1
Authors & Publishers
et al.
7
Ovid
6
JAIDS Journal of Acquired Immune Deficiency Syndromes
4
A. Armstrong
2
C. Irvine
2
J. M. Nagata
2
M. Vicari
2
World Health Organization (WHO)
2
World Health Organization WHO
2
A. H. Sohn
1
A. Judd
1
A. L. Slogrove
1
Ana Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
1
D. Mark
1
E. Geng
1
EFSA
1
EFSA Journal
1
et al
1
European Centre for Disease Prevention and Control ECDC
1
G. Hirnschall
1
G. K. Siberry
1
Government of SomaliaWorld Health Organization WHO
1
Henao-Restrepo, A.M.
1
Journal of Acquired Immune Deficiency Syndromes (JAIDS )
1
Journal of Acquired Immune Deficiency Syndromes (JAIDS)
1
L. Mofenson
1
L.-G. Bekker
1
M. Penazzato
1
M. Schomaker
1
M.-A. Davies
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Pan American Health Organisation PAHO
1
PLOS Medicine
1
S. Vorkorper
1
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
1
Unicef
1
Unitaid
1
World Health Organization
1
Publication Years
Category
Clinical Guidelines
3
Countries
2
Public Health
1
Key Resources
1
Toolboxes
HIV
10
Ebola
2
Rapid Response
2
COVID-19
2
Mental Health
1
Planetary Health
1

A Global Research Agenda for Adolescents Living With HIV

A. Armstrong; J. M. Nagata; M. Vicari; et al. Journal of Acquired Immune Deficiency Syndromes (JAIDS ); Ovid (2018) CC
Supplement Article J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018 www.jaids.com

A Global Research Agenda for Pediatric HIV

M. Penazzato; C. Irvine; M. Vicari; et al Journal of Acquired Immune Deficiency Syndromes (JAIDS); Ovid (2018) CC
Supplement Article www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
Supplement Article J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018 www.jaids.com
WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Supplement Article www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
orientaciones provisionales, 8 de noviembre de 2020 This interim guidance is most useful for countries interested in monitoring relative circulations of influenza and SARS-CoV-2 viruses. The document provides practical information to maintain surveillance of influenza and monitor SARS-CoV-2 using e ... more
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience ... more
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2020 in 27 EU Member States (MS) and nine non-MS. Key statistics on zoonoses and zoonotic agents in humans, food, animals and feed are provided and interpreted historically.
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a ... more
Supplement Article www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released i ... more

Annex 3. Dosages of ARV drugs

World Health Organization (2019) C_WHO
Accessed: 19.10.2019
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d ... more

Ensuring Children and Adolescents Are Not Left Behind

L.-G. Bekker; G. K. Siberry; G. Hirnschall JAIDS Journal of Acquired Immune Deficiency Syndromes; Ovid (2018) C2
Supplement Article J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018 www.jaids.com
Genomic sequencing has been an essential tool in generating virological data, driving the laboratory response, and better understanding the dispersal and evolutionary patterns of SARS-CoV-2. In addition to the characterization of the global circulation patterns, early detection of SARS-CoV-2 variant ... more
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les ... more